The landscape of managing diabetes is evolving with the emergence of skin-applied GLP-1 therapy. These novel patches offer a likely simpler alternative to injections for individuals managing diabetes mellitus type 2 . They deliver glucagon-like peptide-1 directly through the skin , bypassing the